SoylentNews

takyon [soylentnews.org] writes:

Just months after an outcry about a price hike for the life-saving "Epipen" [soylentnews.org], CVS pharmacies will begin carrying a new generic injector at a cutthroat price [arstechnica.com]:

Pharmaceutical giant CVS announced Thursday that it has partnered with Impax Laboratories to sell a generic epinephrine auto-injector for $109.99 [cvshealth.com] for a two-pack—a dramatic cut from Mylan's Epipen two-pack prices, which list for more than $600 as a brand name and $300 as a generic.

The lower-cost auto-injector, a generic form of Adrenaclick, is available starting today nationwide in the company's more than 9,600 pharmacies. Its price resembles that of EpiPen's before Mylan bought the rights to the life-saving devices back in 2007 and raised the price repeatedly, sparking outcry. [...] The price of $109.99 for the alternative applies to those with and without insurance, CVS noted. And Impax is also offering a coupon to reduce the cost to just $9.99 for qualifying patients. [...] Meanwhile, backlash to Mylan's price hikes continue. This week, Cigna, a top health insurance company, said that it will no longer cover Mylan's brand name EpiPen [cnn.com]—it will only cover the generic, which was rolled out in December.

Previously: AllergyStop: $50 EpiPen is Production-Ready but... [soylentnews.org]
Mylan Overcharged U.S. Government on EpiPens [soylentnews.org]

Original Submission